3 surprising facts Prenuvo data shows about belly fat—and how to reduce it

April 10, 2026
X
5
 mins read
WRITTEN BY
Mike Simone
MEDICAL REVIEWED BY
Summary

Belly fat is not one single thing, and the most dangerous type is often the visceral fat you cannot see. Prenuvo data shows that where fat is stored matters more than weight alone, with visceral fat linked to metabolic risk, inflammation, and markers of brain aging. It also highlights a common blind spot. Weight loss, especially when rapid or supported by GLP-1 medications, can come at the expense of muscle, which is important for long-term health. The real goal is not just losing weight. It is reducing visceral fat while preserving muscle, using deeper measurements to guide smarter and more sustainable decisions.

Most people think “belly fat” is one thing: the fat you can pinch. But from a health standpoint, the fat you can’t see is often the more important story.

Weight and BMI can’t tell you where fat is stored, how much of it may surround your organs, or whether weight loss is coming from fat or muscle. Prenuvo’s Whole Body Scan and Body Composition Analysis may help you see what’s there.

Here are three measurable facts that change the belly-fat conversation, plus what you could do about them with the guidance of your doctor.

1. The most harmful belly fat is the one you can’t see

Belly fat can be subcutaneous fat under the skin, but it can also be visceral fat, a type of fat that’s stored deep in the abdomen around your organs.

That distinction matters because Prenuvo internal research shows visceral fat is consistently associated with metabolic risk and inflammation

Prenuvo internal research has also linked higher visceral fat to markers of brain aging, including lower brain volumes in regions vulnerable to Alzheimer’s disease. 

Translation: two people can weigh the same, look similar in the mirror, and still have very different health profiles because one carries more visceral fat.

What you could do about it

If you’re relying mainly on BMI or the scale, you may be missing the bigger picture. Start with measurements that reflect what may actually be happening inside your body such as where fat is stored, not just how much you weigh.

For a deeper look at why BMI falls short, read: Why tracking your BMI is becoming irrelevant.

2. You can lose weight and still lose the wrong thing

Weight loss isn’t automatically the same as improved health.

Rapid weight loss, whether through aggressive dieting or GLP-1 medications, can reduce fat, but it can also lead to meaningful losses in lean mass (muscle). That means the scale can move in the “right” direction while your overall body composition shifts the wrong way.

According to Prenuvo internal research higher muscle volume has been associated with better long-term health outcomes, including markers tied to brain aging

So if you’re taking a GLP-1, the most important question isn’t simply, Am I losing weight? It’s: Am I losing fat while preserving muscle?

What you could do about it

Pair GLP-1 use with resistance training and adequate protein intake, and track body composition so you may be able to see what’s changing beneath the surface.

For a full look at how GLP-1 medications affect the body and why composition tracking matters, read: How weight loss drugs affect your entire body.

3. The real goal is visceral fat down, muscle preserved over time

Most “how to lose belly fat” advice can feel a bit generic.

A more useful and sustainable goal looks like this:

  • reduce visceral fat
  • preserve or build muscle
  • track both over time so you can adjust your approach

Real progress is changing the things that matter most for long-term health, not just a number on a scale.

What you could do about it

Focus on nutrient-dense eating patterns you can maintain, prioritize resistance training, and monitor markers that reflect true progress: visceral fat levels, muscle volume, symmetry, and organ fat where relevant.

For the full set of situations where body composition tracking becomes especially valuable, read: Why you should be tracking your body composition.

See what’s happening beneath the surface

If you want a detailed picture of what’s happening inside your body including your visceral fat, muscle volume, and other key composition markers, a Prenuvo Whole Body Scan and Body Composition Analysis helps provide measurements you can track over time.

To learn more about the benefits of whole body MRI and body composition tracking, book a call with a member of our Patient Services Team.

FAQ

What is visceral fat, and why does it matter more than subcutaneous fat?

Visceral fat is stored deep in the abdomen around your organs and is more strongly associated with metabolic disease, inflammation, and long-term health risks than fat just under the skin.

Why isn’t BMI a reliable way to assess belly fat or health risk?

BMI doesn’t show where fat is stored or distinguish between fat and muscle, meaning two people with the same BMI can have very different internal health profiles.

How do GLP-1 medications affect body composition beyond weight loss?

GLP-1 medications can reduce overall body weight, but they may also lead to a loss of lean muscle alongside fat. Without strategies like resistance training and adequate protein intake, this shift in body composition may impact strength, metabolism, and long-term health.

How can I reduce visceral fat while preserving muscle?

Focus on sustainable nutrition, prioritize resistance training, ensure adequate protein intake, and track body composition instead of relying only on weight.

What is the benefit of tracking body composition over time?

One benefit is that it helps you understand changes beneath the surface, such as reductions in visceral fat and preservation of muscle. This allows you to adjust your approach based on what is actually improving your health.

Citations

Raji, C. A., Meysami, S., Lee, S., Garg, S., Akbari, N., Pompa, R. S., Gouda, A., Nguyen, T. D.,Basar, S., Chodakiewitz, Y. G., Merrill, D. A., Patel, A., Durand, D. J., & Hashemi, S. (2025a). Brain Structure in Type 2 Diabetics with High Visceral Adiposity. Alzheimer’s & Dementia, 21(S8), e109899. https://doi.org/10.1002/alz70862_109899

Raji, C. A., Meysami, S., Lee, S., Garg, S., Akbari, N., Pompa, R. S., Gouda, A., Nguyen, T. D., Basar, S., Chodakiewitz, Y. G., Merrill, D. A., Patel, A., Durand, D. J., & Hashemi, S. (2025b). Higher Muscle Volume is Inversely Related to Chronological and Brain Age While Increased Visceral to Muscle Fat Ratio is Positively Related to Chronological and Brain Age. Alzheimer’s & Dementia, 21(S8), e110051. https://doi.org/10.1002/alz70862_110051

Raji, C. A., Meysami, S., Lee, S., Garg, S., Akbari, N., Pompa, R. S., Gouda, A., Nguyen, T. D., Basar, S., Chodakiewitz, Y. G., Merrill, D. A., Patel, A., Durand, D. J., & Hashemi, S. (2025c). Visceral Adipose Tissue Shows Stronger Links to both Chronological and MRI Predicted Brain Age Compared to Subcutaneous Adipose Tissue. Alzheimer’s & Dementia, 21(S8), e110302. https://doi.org/10.1002/alz70862_110302

Share this

Related articles

How to maintain muscle and strength as you age

September 24, 2025

June 24, 2025

Stay updated on our
latests findings and research

a profile photo a of a man thinking
Open modal